MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Perrigo Co PLC

Cerrado

SectorSalud

27.9 0.87

Resumen

Variación precio

24h

Actual

Mínimo

27.39

Máximo

27.93

Métricas clave

By Trading Economics

Ingresos

-24M

-45M

Ventas

51M

1.1B

P/B

Media del Sector

2,570

63.778

BPA

0.93

Rentabilidad por dividendo

4.14

Margen de beneficio

-3.909

Empleados

8,379

EBITDA

35M

114M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 meses

+20.32% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

4.14%

2.39%

Próximas Ganancias

6 may 2025

Fecha Próximo Dividendo

17 jun 2025

Próxima Fecha de Ex Dividendo

29 may 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

459M

3.8B

Apertura anterior

27.03

Cierre anterior

27.9

Noticias sobre sentimiento de mercado

By Acuity

35%

65%

122 / 386 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bearish Evidence

Perrigo Co PLC Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

28 feb 2025, 17:42 UTC

Principales Movimientos del Mercado

Perrigo Shares Jump on FDA's Move to Reclassify Wisconsin Infant-Formula Plant

27 feb 2025, 23:52 UTC

Ganancias

Perrigo Gets Facility Reclassification From FDA as 4Q Profit, Revenue Fall

Comparación entre iguales

Cambio de precio

Perrigo Co PLC Esperado

Precio Objetivo

By TipRanks

20.32% repunte

Estimación a 12 meses

Media 33.33 USD  20.32%

Máximo 42 USD

Mínimo 27 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Perrigo Co PLC Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

4 ratings

1

Comprar

3

Mantener

0

Vender

Puntuación técnica

By Trading Central

27.36 / 27.81Soporte y Resistencia

Corto Plazo

Bearish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Strong Bullish Evidence

Sentimiento

By Acuity

122 / 386 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Perrigo Co PLC

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.